AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 22980127 — intervention group
Group type: EXPERIMENTAL
Intervention: Ischemia modified albumin (IMA) levels measured before and after treadmill test
Number of subjects: 56
Study 19854793 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine (0.5 microg/kg bolus, followed by continuous infusion at 1‐2 microg/kg/h)
Number of subjects: 30
Study 17388769 — intervention group
Group type: EXPERIMENTAL
Intervention: True acupressure
Number of subjects: 44
Study 17388769 — intervention group
Group type: COMPARATOR
Intervention: Sham acupressure
Number of subjects: 44
Study 15617992 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose chemotherapy (HD-CT) using the CMA regimen (Mitoxantrone, Cyclophosphamide, Melphalan)
Number of subjects: 61
Study 15617992 — intervention group
Group type: COMPARATOR
Intervention: Conventional chemotherapy (CT)
Number of subjects: 61
Study 12208242 — intervention group
Group type: EXPERIMENTAL
Intervention: Optic nerve sheath decompression surgery
Number of subjects: 418
Study 12208242 — intervention group
Group type: COMPARATOR
Intervention: Careful follow-up
Number of subjects: 418
Study 10362194 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin and ACE inhibitors
Number of subjects: 11575
Study 10362194 — intervention group
Group type: COMPARATOR
Intervention: ACE inhibitors without aspirin
Number of subjects: 11575
Study 10362194 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin and ACE inhibitors in congestive heart failure patients
Number of subjects: 11575
Study 10362194 — intervention group
Group type: COMPARATOR
Intervention: ACE inhibitors without aspirin in congestive heart failure patients
Number of subjects: 11575
Study 7589340 — intervention group
Group type: EXPERIMENTAL
Intervention: 13‐cis‐retinoic acid (10 to 60 mg/m2/daily) administered in combination with vitamin E for 3 months to 5 years
Number of subjects: 34
Study 2119982 — intervention group
Group type: EXPERIMENTAL
Intervention: Norplant-2
Number of subjects: 200
Study 2119982 — intervention group
Group type: COMPARATOR
Intervention: Levonorgestrel-releasing IUD (LNG-IUD)
Number of subjects: 200
Study 2119982 — intervention group
Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 200
Study 474345 — intervention group
Group type: EXPERIMENTAL
Intervention: Feedback goniometers used during active range-of-motion exercises
Number of subjects: 0
Study 31995576 — intervention group
Group type: EXPERIMENTAL
Intervention: Admixture and mtDNA tests
Number of subjects: 0
Study 31995576 — intervention group
Group type: COMPARATOR
Intervention: No tests
Number of subjects: 0
Study 31354000 — intervention group
Group type: EXPERIMENTAL
Intervention: HIGH (supervised, multimodal exercise including heavy-load resistance exercise: 85-90% 1 repetition maximum [RM], three sets of 5-8 repetitions)
Number of subjects: 153
Study 31354000 — intervention group
Group type: COMPARATOR
Intervention: LOW (pedometer and one-on-one consultations)
Number of subjects: 153
Study 28743191 — intervention group
Group type: EXPERIMENTAL
Intervention: Electronic patient-reported outcome diary
Number of subjects: 311
Study 28352711 — intervention group
Group type: EXPERIMENTAL
Intervention: SLING-IUFT
Number of subjects: 154
Study 28352711 — intervention group
Group type: COMPARATOR
Intervention: TVT-Exact
Number of subjects: 154
Study 23278879 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary intervention
Number of subjects: 46
Study 23278879 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise intervention
Number of subjects: 46
Study 23278879 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined dietary and exercise intervention
Number of subjects: 46
Study 21525520 — intervention group
Group type: EXPERIMENTAL
Intervention: 500,000 IU vitamin D(3) (cholecalciferol) orally every autumn/winter for 3-5 consecutive years
Number of subjects: 0
Study 21525520 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 21525520 — intervention group
Group type: EXPERIMENTAL
Intervention: 500,000 IU vitamin D(3) (cholecalciferol)
Number of subjects: 0
Study 19387807 — intervention group
Group type: EXPERIMENTAL
Intervention: Protocol A - Enoxaparin 1 mg/kg x ten doses
Number of subjects: 539
Study 19387807 — intervention group
Group type: EXPERIMENTAL
Intervention: Protocol B - Enoxaparin 1 mg/kg x six doses
Number of subjects: 539
Study 19387807 — intervention group
Group type: EXPERIMENTAL
Intervention: Protocol C - Enoxaparin 0.5 mg/kg x six doses
Number of subjects: 539
Study 16965205 — intervention group
Group type: EXPERIMENTAL
Intervention: Concomitant psychotropic medications (CPMs) - antidepressants
Number of subjects: 53
Study 16965205 — intervention group
Group type: EXPERIMENTAL
Intervention: Concomitant psychotropic medications (CPMs) - mood stabilizers
Number of subjects: 53
Study 16965205 — intervention group
Group type: EXPERIMENTAL
Intervention: Concomitant psychotropic medications (CPMs) - modafinil and trazodone
Number of subjects: 53
Study 16965205 — intervention group
Group type: EXPERIMENTAL
Intervention: Concomitant psychotropic medications (CPMs) - sleeping medications
Number of subjects: 53
Study 15225174 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-erosive reflux disease
Number of subjects: 145
Study 15225174 — intervention group
Group type: COMPARATOR
Intervention: Functional heartburn
Number of subjects: 145
Study 12419032 — intervention group
Group type: EXPERIMENTAL
Intervention: rLH supplementation with rFSH (Group A)
Number of subjects: 453
Study 12419032 — intervention group
Group type: COMPARATOR
Intervention: rFSH only (Group B)
Number of subjects: 453
Study 9523960 — intervention group
Group type: EXPERIMENTAL
Intervention: Initial injection into the midcarpal and distal radioulnar joints
Number of subjects: 100
Study 9523960 — intervention group
Group type: COMPARATOR
Intervention: Initial injection into the radiocarpal joint
Number of subjects: 100
Study 7660509 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral face‐to‐face interview
Number of subjects: 475
Study 7660509 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone interview
Number of subjects: 475
Study 7660509 — intervention group
Group type: COMPARATOR
Intervention: Self‐administered questionnaires
Number of subjects: 475
Study 2625214 — intervention group
Group type: EXPERIMENTAL
Intervention: Right forced unilateral nostril breathing (FUNB)
Number of subjects: 0
Study 2625214 — intervention group
Group type: EXPERIMENTAL
Intervention: Left forced unilateral nostril breathing (FUNB)
Number of subjects: 0
Study 686527 — intervention group
Group type: EXPERIMENTAL
Intervention: BCG immunotherapy
Number of subjects: 55
Study 686527 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 55
Study 31359813 — intervention group
Group type: EXPERIMENTAL
Intervention: Needle-free injector (NFI)
Number of subjects: 62
Study 31359813 — intervention group
Group type: COMPARATOR
Intervention: Glargine pen (GP)
Number of subjects: 62
Study 28131974 — intervention group
Group type: EXPERIMENTAL
Intervention: 3TG (three 60min sessions/week)
Number of subjects: 58
Study 28131974 — intervention group
Group type: COMPARATOR
Intervention: 2TG (two 60min sessions/week)
Number of subjects: 58
Study 25911987 — intervention group
Group type: EXPERIMENTAL
Intervention: narafilcon A
Number of subjects: 39
Study 25911987 — intervention group
Group type: EXPERIMENTAL
Intervention: delefilcon A
Number of subjects: 39
Study 25911987 — intervention group
Group type: EXPERIMENTAL
Intervention: filcon II 3
Number of subjects: 39
Study 25911987 — intervention group
Group type: EXPERIMENTAL
Intervention: All brands
Number of subjects: 39
Study 23571304 — intervention group
Group type: EXPERIMENTAL
Intervention: directive counseling and sound therapy using conventional sound generators
Number of subjects: 228
Study 23571304 — intervention group
Group type: EXPERIMENTAL
Intervention: directive counseling and placebo sound generators
Number of subjects: 228
Study 23571304 — intervention group
Group type: COMPARATOR
Intervention: standard of care as administered in the military
Number of subjects: 228
Study 23571304 — intervention group
Group type: EXPERIMENTAL
Intervention: conventional sound generators
Number of subjects: 228
Study 23571304 — intervention group
Group type: EXPERIMENTAL
Intervention: placebo sound generators
Number of subjects: 228
Study 21393623 — intervention group
Group type: EXPERIMENTAL
Intervention: HIV prevention program
Number of subjects: 246
Study 21393623 — intervention group
Group type: COMPARATOR
Intervention: Health education program
Number of subjects: 246
Study 19528519 — intervention group
Group type: EXPERIMENTAL
Intervention: Donepezil treatment
Number of subjects: 756
Study 19528519 — intervention group
Group type: COMPARATOR
Intervention: Combined vitamin E and placebo groups
Number of subjects: 756
Study 19528519 — intervention group
Group type: COMPARATOR
Intervention: Nondepressed participants
Number of subjects: 756
Study 17159758 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 mL/kg of hydroxyethyl starch 6% (Group A)
Number of subjects: 40
Study 17159758 — intervention group
Group type: COMPARATOR
Intervention: Control group (Group B)
Number of subjects: 40
Study 15571637 — intervention group
Group type: EXPERIMENTAL
Intervention: comicronized fenofibrate 200 mg daily
Number of subjects: 9795
Study 15571637 — intervention group
Group type: COMPARATOR
Intervention: matching placebo
Number of subjects: 9795
Study 11213597 — intervention group
Group type: EXPERIMENTAL
Intervention: Acarbose (52 patients)
Number of subjects: 100
Study 11213597 — intervention group
Group type: COMPARATOR
Intervention: Placebo (48 patients)
Number of subjects: 100
Study 9763251 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal nicotine
Number of subjects: 10
Study 9763251 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal nicotine and smoking cessation
Number of subjects: 10
Study 9763251 — intervention group
Group type: COMPARATOR
Intervention: Nonsmoking controls
Number of subjects: 10
Study 29276018 — intervention group
Group type: EXPERIMENTAL
Intervention: Health Action Process Approach
Number of subjects: 1933
Study 28851399 — intervention group
Group type: EXPERIMENTAL
Intervention: Simple dressing
Number of subjects: 0
Study 28851399 — intervention group
Group type: EXPERIMENTAL
Intervention: Tissue-glue as a dressing
Number of subjects: 0
Study 28851399 — intervention group
Group type: COMPARATOR
Intervention: No dressing
Number of subjects: 0
Study 26096013 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-invasive ventilation during airway clearance treatments
Number of subjects: 40
Study 26096013 — intervention group
Group type: COMPARATOR
Intervention: Comprehensive inpatient care (control group)
Number of subjects: 40
Study 23477676 — intervention group
Group type: EXPERIMENTAL
Intervention: Off-pump CABG
Number of subjects: 4752
Study 23477676 — intervention group
Group type: COMPARATOR
Intervention: On-pump CABG
Number of subjects: 4752
Study 19519911 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise
Number of subjects: 1334
Study 19519911 — intervention group
Group type: EXPERIMENTAL
Intervention: Manipulation
Number of subjects: 1334
Study 19519911 — intervention group
Group type: EXPERIMENTAL
Intervention: Manipulation followed by exercise
Number of subjects: 1334
Study 19519911 — intervention group
Group type: COMPARATOR
Intervention: Best care in general practice
Number of subjects: 1334
Study 17720102 — intervention group
Group type: COMPARATOR
Intervention: Control group (n=27) received dietary advice to match intake with 1.2 g of protein per kg of ideal body weight and 25 cal/kg ideal body weight.
Number of subjects: 59
Study 17720102 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (n=28) received dietary advice to match energy intake with estimated total energy expenditure, with a protein intake of 0.8 to 1.0 g/kg.
Number of subjects: 59
Study 14728998 — intervention group
Group type: EXPERIMENTAL
Intervention: Hormonal replacement therapy (androgens)
Number of subjects: 0
Study 11142664 — intervention group
Group type: EXPERIMENTAL
Intervention: Elastase activity measured in gingival crevicular fluid (GCF)
Number of subjects: 12
Study 9833603 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous infusion of 30 g L-arginine
Number of subjects: 8
Study 9833603 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous infusion of 6 g L-arginine
Number of subjects: 8
Study 9833603 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral ingestion of 6 g L-arginine
Number of subjects: 8
Study 9833603 — intervention group
Group type: COMPARATOR
Intervention: Placebo (for comparison)
Number of subjects: 8
Study 7867963 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive impairment, particularly impaired orientation
Number of subjects: 88
Study 7867963 — intervention group
Group type: EXPERIMENTAL
Intervention: Evidence of previous cerebrovascular accident
Number of subjects: 88
Study 7867963 — intervention group
Group type: EXPERIMENTAL
Intervention: Incoordination as measured clinically
Number of subjects: 88
Study 7867963 — intervention group
Group type: EXPERIMENTAL
Intervention: Inability to perform the 'Get‐up‐and‐go' test
Number of subjects: 88
Study 7867963 — intervention group
Group type: EXPERIMENTAL
Intervention: Use of psycho‐active medications
Number of subjects: 88
Study 7867963 — intervention group
Group type: EXPERIMENTAL
Intervention: Impaired orientation, psycho‐active drug use, evidence of stroke, and impaired performance in the 'Get‐up‐and‐go' test
Number of subjects: 88
Study 7867963 — intervention group
Group type: EXPERIMENTAL
Intervention: Number of identified risk factors
Number of subjects: 88
Study 2774232 — intervention group
Group type: EXPERIMENTAL
Intervention: Thoracic epidural anesthesia plus light general anesthesia (group TEA)
Number of subjects: 105
Study 2774232 — intervention group
Group type: COMPARATOR
Intervention: General anesthesia with halothane (group H)
Number of subjects: 105
Study 2774232 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuroleptanalgesia (group NLA)
Number of subjects: 105
Study 561495 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone (12 mg per day orally for three successive days)
Number of subjects: 0
Study 31433573 — intervention group
Group type: EXPERIMENTAL
Intervention: 4-odorant training (PEA, lemon, eucalyptus, clove oils)
Number of subjects: 90
Study 31433573 — intervention group
Group type: COMPARATOR
Intervention: PEA training (1 bottle of PEA)
Number of subjects: 90
Study 24863414 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral antioxidant cocktail (vitamin C, 1000 mg; vitamin E, 600 IU; alpha‐lipoic acid, 600 mg)
Number of subjects: 12
Study 24863414 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 23800565 — intervention group
Group type: EXPERIMENTAL
Intervention: Creatine supplementation (0.3 g/kg for 7 days)
Number of subjects: 25
Study 23800565 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study 21716269 — intervention group
Group type: EXPERIMENTAL
Intervention: Fenofibrate
Number of subjects: 200
Study 18769961 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 microg/day of transdermal 17beta‐estradiol for 4 weeks
Number of subjects: 34
Study 18769961 — intervention group
Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 34
Study 17934931 — intervention group
Group type: EXPERIMENTAL
Intervention: promestriene 10 mg daily, by vaginal capsule, for 21 days before the operation
Number of subjects: 98
Study 17934931 — intervention group
Group type: COMPARATOR
Intervention: TVT (Tension‐free Vaginal Tape) surgical procedure without pharmacological preparation
Number of subjects: 98
Study 15246941 — intervention group
Group type: EXPERIMENTAL
Intervention: Short contact dithranol
Number of subjects: 250
Study 15246941 — intervention group
Group type: EXPERIMENTAL
Intervention: UVB-phototherapy
Number of subjects: 250
Study 15246941 — intervention group
Group type: EXPERIMENTAL
Intervention: Inpatient dithranol treatment
Number of subjects: 250
Study 11482615 — intervention group
Group type: EXPERIMENTAL
Intervention: Active counterpositioning
Number of subjects: 74
Study 11482615 — intervention group
Group type: COMPARATOR
Intervention: Orthotic helmets
Number of subjects: 74
Study 9611022 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramedullary hip-screw
Number of subjects: 100
Study 9611022 — intervention group
Group type: COMPARATOR
Intervention: Compression hip-screw with plate
Number of subjects: 100
Study 7825753 — intervention group
Group type: EXPERIMENTAL
Intervention: Impedance cardiography (ZCG) during exercise
Number of subjects: 7
Study 7825753 — intervention group
Group type: EXPERIMENTAL
Intervention: Impedance cardiography (ZCG) during upright exercise
Number of subjects: 7
Study 7825753 — intervention group
Group type: COMPARATOR
Intervention: SVZCG compared with SVCO2
Number of subjects: 7
Study 7825753 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulse-O2 as an index to SV
Number of subjects: 7
Study 7825753 — intervention group
Group type: EXPERIMENTAL
Intervention: ZCG parameters dZ/dtmax and LVET
Number of subjects: 7
Study 7825753 — intervention group
Group type: EXPERIMENTAL
Intervention: SVZCG calculated with the Kubicek equation
Number of subjects: 7
Study 3071615 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceftriaxone (CTRX) 10 mg/kg
Number of subjects: 168
Study 3071615 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceftriaxone (CTRX) 20 mg/kg
Number of subjects: 168
Study 3071615 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceftriaxone (CTRX)
Number of subjects: 168
Study 29388802 — intervention group
Group type: EXPERIMENTAL
Intervention: Graphic health warnings (GHWs) evoked negative emotions high in arousal activation
Number of subjects: 0
Study 29388802 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive reactions to GHWs
Number of subjects: 0
Study 29388802 — intervention group
Group type: EXPERIMENTAL
Intervention: Perceived health risks of smoking
Number of subjects: 0
Study 29388802 — intervention group
Group type: EXPERIMENTAL
Intervention: GHW-evoked negative emotions
Number of subjects: 0
Study 27754998 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Velocity Resistance Training (HV)
Number of subjects: 46
Study 27754998 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-Velocity Resistance Training (LV)
Number of subjects: 46
Study 25804431 — intervention group
Group type: EXPERIMENTAL
Intervention: Perk Tutor (3D display with conventional ultrasound imaging)
Number of subjects: 24
Study 25804431 — intervention group
Group type: COMPARATOR
Intervention: Control (conventional ultrasound only)
Number of subjects: 24
Study 24105750 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon α-2b, 3 MU three times weekly for 18 months
Number of subjects: 221
Study 24105750 — intervention group
Group type: COMPARATOR
Intervention: No treatment (control group)
Number of subjects: 221
Study 21867991 — intervention group
Group type: EXPERIMENTAL
Intervention: Antidepressant treatment for 8 weeks
Number of subjects: 27
Study 21867991 — intervention group
Group type: COMPARATOR
Intervention: Healthy control subjects
Number of subjects: 27
Study 19264721 — intervention group
Group type: EXPERIMENTAL
Intervention: EHF‐LGG
Number of subjects: 0
Study 19264721 — intervention group
Group type: EXPERIMENTAL
Intervention: PHF‐LGG
Number of subjects: 0
Study 19264721 — intervention group
Group type: COMPARATOR
Intervention: EHF
Number of subjects: 0
Study 19264721 — intervention group
Group type: EXPERIMENTAL
Intervention: EHF and PHF‐LGG
Number of subjects: 0
Study 17364603 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 102
Study 17364603 — intervention group
Group type: EXPERIMENTAL
Intervention: Applied Relaxation
Number of subjects: 102
Study 17364603 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal Estrogens
Number of subjects: 102
Study 17364603 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral Estrogens
Number of subjects: 102
Study 17364603 — intervention group
Group type: COMPARATOR
Intervention: Transdermal Placebo
Number of subjects: 102
Study 15465845 — intervention group
Group type: EXPERIMENTAL
Intervention: Leucocyte depleting arterial line filter
Number of subjects: 32
Study 15465845 — intervention group
Group type: COMPARATOR
Intervention: Standard 40-mm arterial line filter
Number of subjects: 32
Study 11887429 — intervention group
Group type: EXPERIMENTAL
Intervention: Margarine
Number of subjects: 77
Study 11887429 — intervention group
Group type: COMPARATOR
Intervention: Butter
Number of subjects: 77
Study 9840216 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental sustained release tablet containing dextromethorphan hydrobromide (DXP‐HBr)
Number of subjects: 6
Study 9840216 — intervention group
Group type: COMPARATOR
Intervention: Marketed sustained release DXP‐HBr suspension
Number of subjects: 6
Study 8040016 — intervention group
Group type: EXPERIMENTAL
Intervention: Neurosurgery plus radiotherapy
Number of subjects: 66
Study 8040016 — intervention group
Group type: COMPARATOR
Intervention: Radiotherapy alone
Number of subjects: 66
Study 8040016 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 66
Study 8040016 — intervention group
Group type: EXPERIMENTAL
Intervention: Age factor
Number of subjects: 66
Study 2690314 — intervention group
Group type: EXPERIMENTAL
Intervention: Famotidine (40 mg)
Number of subjects: 18
Study 2690314 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranitidine (300 mg)
Number of subjects: 18
Study 2690314 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 786677 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine, 10 mg sublingually
Number of subjects: 10
Study 31397261 — intervention group
Group type: EXPERIMENTAL
Intervention: Teen Mental Health First Aid (MHFA) training
Number of subjects: 2251
Study 31397261 — intervention group
Group type: EXPERIMENTAL
Intervention: eLearning MHFA
Number of subjects: 2251
Study 31397261 — intervention group
Group type: EXPERIMENTAL
Intervention: Blended eLearning MHFA
Number of subjects: 2251
Study 31397261 — intervention group
Group type: COMPARATOR
Intervention: Physical first aid training
Number of subjects: 2251
Study 31397261 — intervention group
Group type: COMPARATOR
Intervention: eLearning physical first aid
Number of subjects: 2251
Study 30084233 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.0625 mg linaclotide
Number of subjects: 382
Study 30084233 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.125 mg linaclotide
Number of subjects: 382
Study 30084233 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.25 mg linaclotide
Number of subjects: 382
Study 30084233 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5 mg linaclotide
Number of subjects: 382
Study 30084233 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 382
Study 26086326 — intervention group
Group type: EXPERIMENTAL
Intervention: Interval training (IT) program at 70-110% of workload reached at the ventilatory anaerobic threshold (VAT) for 16 weeks, 30-40 minutes each session, 3 times a week.
Number of subjects: 64